Med Ad News, PharmaLive.com sold

Share this article:

Med Ad News and PharmaLive.com publisher, Engel Publishing Partners, has been acquired by Los Angeles-based Canon Communications, Canon announced today. Financial terms of the deal were not disclosed.

Canon, a division of Apprise Media, produces magazine titles and trade shows focused on the medical device, specialty packaging, materials processing, and plastics processing industries.

Canon currently maintains several medical titles including MD&DI (Medical Device & Diagnostic Industry), Medical Product Manufacturing News, Medical Electronics Manufacturing, European Medical Device Manufacturer and others. Canon's digital media holdings include the medical device design and engineering portal, Medical Device Link; online magazine, Advanced Design & Manufacturing (AD&M) and various e-newsletters and e-publications.

Next month, Canon will launch its BIOMEDevice trade show, to provide “a forum for areas where the pharmaceutical and medical device manufacturing markets are converging,” said Charles McCurdy, Canon CEO.

Engel Publishing, based in Newtown, PA, was established in 1982. Its monthly Med Ad News publication covers business and marketing activities in the pharmaceutical industry.

Engel's R&D Directions title was established in 1995 and is published 10 times a year. R&D Directions' target audience is comprised of research and development professionals at pharmaceutical companies.

PharmaLive.com reports 150,000 unique visitors each month with 65,000 professionals registered to receive its e-newsletters.

Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.